Lupin launches Luforbec 100/6 to treat adult asthma and COPD in Germany

Hormosan Pharma GmbH (Hormosan), Lupin’s wholly-owned subsidiary in Germany, announced the launch of Luforbec 100/6 (beclometasone 100 µg/formoterol 6 µg), a fix combination in a pressurized metered dose inhaler (pMDI) for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD) in Germany.
 
Luforbec 100µg/6µg pMDI is indicated for adult asthma and COPD treatment, where the use of an inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) is suitable. With the same active ingredients as Foster 100/6 pMDI and an extra fine formulation, Luforbec offers the same licensed indications and similar device characteristics. Luforbec pMDI provide significant cost savings, priced at - 47% below the fixed reference price on the pharmacy selling price.
 
With a significant portion of the population (5% of adults and 10% of children) currently undergoing asthma treatment, Luforbec 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals. This launch reflects Lupin’s unwavering commitment to addressing the critical needs of asthma management in Germany.
 
Anjan Selz, managing director, Hormosan Pharma GmbH, added, "The launch of Luforbec 100/6 pMDI in Germany represents a significant milestone in our goal to establish Hormosan as a key player in the inhalation segment. We are committed to improving healthcare outcomes by ensuring the accessibility and affordability of reliable and comprehensive solutions for patients and healthcare professionals. This launch reinforces our dedication to making asthma and COPD management more accessible for the German population."
 
Luforbec 100µg/6µg is indicated in the regular treatment of asthma where the use of a combination product (inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) is appropriate. This includes patients not adequately controlled with ICS and ‘as needed’ inhaled short-acting beta2-agonist or patients already adequately controlled on both ICS and LABA.
 
Luforbec 100µg/6µg is also indicated in the symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
 
Hormosan Pharma GmbH was founded in Germany more than 50 years ago and has been a part of Lupin since 2008. With innovative and generic drugs, Hormosan supports the best possible treatment in the fields of neurology, pain therapy, sexual health, and inhalation. It focuses primarily on addressing the unmet medical needs of patients, the increased inpatient benefit, and the availability of alternative therapy options.
 
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!